The use of High Specific Activity Radionuclides HSARNs, obtained by either proton, deuteron or alpha cyclotron irradiation, followed by selective radiochemical separation from the irradiated target in No Carrier Added (NCA) form, is a powerful analytical tool. The main applications of these radionuclides are to medical diagnosis and therapy in addition to toxicological, environmental and industrial studies. Some examples of production and radioanalytical quality control methods for HSARNs are presented.
Cyclotron radionuclide production for biomedical applications / F. Groppi, M. Bonardi, Z.B. Alfassi, L. Gini - In: Proceedings of DAE-BRNS symposium on nuclear and radiochemistry : NUCAR 2009 : 7–10 January, 2009, Mumbai, India / [a cura di] A. R. Joshi, S. K. Thulasidas, R. M. Sawant, B. K. Sen, V. Venugopal. - Mumbai : Perfect Prints, 2009. - pp. 64-70 (( convegno Nuclear and radiochemistry symposium : NUCAR tenutosi a Mumbai (India) nel 2009.
Cyclotron radionuclide production for biomedical applications
F. GroppiPrimo
;M. BonardiSecondo
;
2009
Abstract
The use of High Specific Activity Radionuclides HSARNs, obtained by either proton, deuteron or alpha cyclotron irradiation, followed by selective radiochemical separation from the irradiated target in No Carrier Added (NCA) form, is a powerful analytical tool. The main applications of these radionuclides are to medical diagnosis and therapy in addition to toxicological, environmental and industrial studies. Some examples of production and radioanalytical quality control methods for HSARNs are presented.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
